The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature
Romanian Journal of Morphology and Embryology · 30.12.2020 · 61 (2) · 335-343
DOI: 10.47162/rjme.61.2.03 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Romanian Journal of Morphology and Embryology, 2020. Verfasst von Octavian Munteanu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Polizu Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; tiberiuaugustin.georgescu@gm…. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Anencephaly is a severe malformation of the central nervous system (CNS), being one of the most common types of neural tube defects. It is defined as total or partial absence of the calvarium, with absence of the brain. Anencephaly has an incidence of 1 to 5 in every 1000 births, and the mortality rate is 100% during intrauterine life or within hours or days after birth. The etiology of anencephaly remains unclear, but various maternal-related environmental and genetic risk factors have been reported, which include diabetes, obesity, exposure to different drugs or toxins, genetic polymorphisms and mutations, as well as positive family history for neural tube defects. One of the most important nutritional factors in the development of anencephaly is folate deficiency. Methylenetetrahydrofolate reductase (MTHFR) gene codes the enzyme involved in the intracellular metabolism of folic acid; the 677C-T polymorphism of this gene causes the thermolability of the enzyme and decreased enzymatic activity, which is also dependent of folate plasmatic level. Etiopathogenesis of anencephaly includes several mutations in various other genes, such as: platelet-derived growth factor receptor alpha (PDGFRA), cadherin epidermal growth factor (EGF) laminin G (LAG) seven-pass G-type receptor 1 (CELSR1), Vang-like 1 (VANGL1) and Vang-like 2 (VANGL2), the last two being involved in the process of neurulation. Screening tests include maternal serum alpha-fetoprotein level and ultrasound (US) examination. During the first trimester US screening, anencephaly is now detected in all cases, but in order to decrease the complication rate of pregnancy termination, the diagnosis should be established as soon as possible, during the pregnancy confirmation US. We conclude that given that anencephaly is a severe malformation of the CNS, morphological characterization could improve the screening by US that is mandatory in the first trimester in order to plan the best, safe and early management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pathology, Polizu Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania; tiberiuaugustin.georgescu@gmail.com; Department of Behavioral Sciences, Carol Davila University of…
Zitieren
APA
Munteanu, O., Cîrstoiu, M. M., Filipoiu, F. M., Neamţu, M. N., Stavarache, I., Georgescu, T. A., Bratu, O. G., Iorgulescu, G., & Bohîlţea, R. E. (2020). The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature. Romanian Journal of Morphology and Embryology, 61(2), 335-343. https://doi.org/10.47162/rjme.61.2.03
Vancouver
Munteanu O, Cîrstoiu MM, Filipoiu FM, Neamţu MN, Stavarache I, Georgescu TA, et al. The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature. Romanian Journal of Morphology and Embryology. 2020;61(2):335-343. doi:10.47162/rjme.61.2.03
BibTeX
@article{Munteanu2020,
author = {Munteanu, Octavian and Cîrstoiu, Monica Mihaela and Filipoiu, Florin Mihail and Neamţu, Maria Narcisa and Stavarache, Irina and Georgescu, Tiberiu Augustin and Bratu, Ovidiu Gabriel and Iorgulescu, Gabriela and Bohîlţea, Roxana Elena},
title = {The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature},
journal = {Romanian Journal of Morphology and Embryology},
year = {2020},
volume = {61},
number = {2},
pages = {335--343},
doi = {10.47162/rjme.61.2.03}
}
EUVIMED